Regeneron stock popped Thursday after its Sanofi-partnered allergic conditions drug, Dupixent, easily beat third-quarter calls. The post Regeneron, Sanofi Surge As Dupixent Wallops Sales Forecasts appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real